SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes

Current treatments for diabetic retinopathy (DR) target late stages when vision has already been significantly affected. Accumulating evidence suggests that neuroinflammation plays a major role in the pathogenesis of DR, resulting in the disruption of the blood-retinal barrier. Suppressors of cytoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, Cristina, Bogdanov, Patricia, Gómez-Guerrero, Carmen, Sampedro, Joel, Solà-Adell, Cristina, Espejo, Carmen, García-Ramírez, Marta, Prieto, Ignacio, Egido, Jesús, Simó, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695852/
https://www.ncbi.nlm.nih.gov/pubmed/31344857
http://dx.doi.org/10.3390/ijms20153615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695852/
https://www.ncbi.nlm.nih.gov/pubmed/31344857
http://dx.doi.org/10.3390/ijms20153615

Ejemplares similares